Cargando…
1-(4-Methoxyphenylsulfonyl)-5-methyl-5-phenylimidazolidine-2,4-dione
The title compound, C(17)H(16)N(2)O(5)S, crystallized in the chiral monoclinic space group P2(1), with two enantiomeric molecules (A and B) in the asymmetric unit. It is composed of a methylimidazolidine-2,4-dione unit substituted with a phenyl group and a 4-methoxyphenylsulfonyl group. The ben...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969567/ https://www.ncbi.nlm.nih.gov/pubmed/21583077 http://dx.doi.org/10.1107/S1600536809016092 |
Sumario: | The title compound, C(17)H(16)N(2)O(5)S, crystallized in the chiral monoclinic space group P2(1), with two enantiomeric molecules (A and B) in the asymmetric unit. It is composed of a methylimidazolidine-2,4-dione unit substituted with a phenyl group and a 4-methoxyphenylsulfonyl group. The benzene ring mean planes are inclined to one another by 22.20 (14)° in molecule A and by 15.82 (13)° in molecule B. In the crystal structure, the A and B molecules are linked by N—H⋯O hydrogen bonds, forming centrosymmetric dimers. A number of C—H⋯O interactions are also present in the crystal structure, leading to the formation of a three-dimensinoal network. |
---|